Arecor Therapeutics plc
(“Arecor” or the “Group”)
ARECOR GRANTED KEY U.S. PATENT PROTECTING PROPRIETARY INSULIN PRODUCTS
Further strengthens the Company’s extensive patent portfolio protecting its proprietary Arestat™ technology and diabetes product portfolio
BioIVT, a leading provider of research models and services for drug and diagnostic development, today announced that it will be presenting initial results from two of its hepatocyte research projects at the 2022 Society of Toxicology Annual Meeting and ToxExpo. The conference will be held from March 27-31 both virtually and in person in San Diego, CA.
Nottingham-based contract research organisation (CRO) Cellomatics Biosciences has appointed Anand Krishna as senior director to oversee customer engagement and strategy and support its continued growth plans.
Anand brings over 25 years of executive leadership and field sales management experience in companies ranging from VC-funded dotcom start-ups, to managing sales across portfolios in tier 1 technology systems and operations integrators. His career has seen him lead and work with teams across the US, UK, Europe, India, and the Far East.
SAN DIEGO, March 16, 2022 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) has invested in seven new genomics companies to join the fourth global funding cycle of Illumina Accelerator San Francisco Bay Area and Cambridge, UK. The global company creation engine is focused on partnering with entrepreneurs to build breakthrough genomics startups and its next global funding cycle application deadline is April 1, 2022.
Illumina Accelerator is accepting applications this month for its next global cohort of genomics startups, the deadline is April 1.
Monument Tx CSO to present novel biomarker predicting risk for developing POCD at AD/PD conference in Barcelona 15-20th March 2022
Monument Tx CSO to present preclinical data for lipid reformulation of anti-inflammatory compound MT1980 at AD/PD conference in Barcelona 15-20th March 2022
SCIENCE AND INNOVATION SECTORS IN CAMBRIDGE DRIVE GROWTH IN REGIONAL EMPLOYMENT DESPITE PANDEMIC TURBULENCE
Information technology, telecommunications, and the life sciences remain the largest and most dynamic of the knowledge intensive sectors
• The Lab Hotel provides free laboratory and office accommodation for start-up companies for six months.
• Applications to join the Lab Hotel are welcome from start-ups working in advanced therapeutics and drug discovery.
• Companies in the Lab Hotel have access to scientific and business support while they develop their innovations and secure their next round of funding.
Coventry, United Kingdom, 10th March 2022 / NanoSyrinx, a biotech company using synthetic biology approaches to develop a new modality for the targeted intracellular delivery of biologic therapeutics, has strengthened its management team with the appointment of Dr Marie McAvoy as its Chief Scientific Officer.
Huge demand for commercial lab and office space at Newcastle’s Biosphere means private sector investment is now being sought to take the lead on expanding the heart of the north east’s £1.7bn life science eco-system.
Located at Newcastle Helix, The Biosphere launched in 2019 as a publicly funded project, led by Newcastle City Council; it represented a significant investment for the local economy and showed a clear commitment to life sciences growth.